1. Home
  2. EMBC

as of 12-15-2025 10:27am EST

$11.83
+$0.07
+0.60%
Stocks Health Care Medical/Dental Instruments Nasdaq

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Chart Type:
Time Range:
Founded: 1924 Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: 719.7M IPO Year: N/A
Target Price: $18.50 AVG Volume (30 days): 781.4K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
5.08%
Dividend Payout Frequency: Quarterly
EPS: 1.62 EPS Growth: 20.90
52 Week Low/High: $9.20 - $21.23 Next Earning Date: 11-25-2025
Revenue: $1,080,400,000 Revenue Growth: -3.80%
Revenue Growth (this year): 2.18% Revenue Growth (next year): 0.09%

AI-Powered EMBC Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 16 hours ago

AI Recommendation

hold
Model Accuracy: 79.74%
79.74%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: